417 related articles for article (PubMed ID: 27067638)
1. Aromatase expression and regulation in breast and endometrial cancer.
Zhao H; Zhou L; Shangguan AJ; Bulun SE
J Mol Endocrinol; 2016 Jul; 57(1):R19-33. PubMed ID: 27067638
[TBL] [Abstract][Full Text] [Related]
2. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
3. Aromatase excess in cancers of breast, endometrium and ovary.
Bulun SE; Chen D; Lu M; Zhao H; Cheng Y; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Su E; Marsh E; Hakim A; Yin P; Ishikawa H; Amin S; Imir G; Gurates B; Attar E; Reierstad S; Innes J; Lin Z
J Steroid Biochem Mol Biol; 2007; 106(1-5):81-96. PubMed ID: 17590327
[TBL] [Abstract][Full Text] [Related]
4. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
[TBL] [Abstract][Full Text] [Related]
5. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
7. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
9. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
10. Sources of estrogen and their importance.
Simpson ER
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional control of local estrogen formation by aromatase in the breast.
To SQ; Knower KC; Cheung V; Simpson ER; Clyne CD
J Steroid Biochem Mol Biol; 2015 Jan; 145():179-86. PubMed ID: 24846828
[TBL] [Abstract][Full Text] [Related]
12. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
13. Organization of the human aromatase p450 (CYP19) gene.
Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
[TBL] [Abstract][Full Text] [Related]
14. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
15. Estrogen production and action.
Nelson LR; Bulun SE
J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
17. Modulation of aromatase expression in human breast tissue.
Chen S; Zhou D; Yang C; Okubo T; Kinoshita Y; Yu B; Kao YC; Itoh T
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):35-40. PubMed ID: 11850205
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
[TBL] [Abstract][Full Text] [Related]
19. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
20. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.
Deb S; Zhou J; Amin SA; Imir AG; Yilmaz MB; Lin Z; Bulun SE
J Biol Chem; 2006 Feb; 281(5):2585-97. PubMed ID: 16303757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
